sample_id	patient_cohort	age	sex	diagnosis	stage	plasma_CA19_9	creatinine	LYVE1	REG1B	TFF1	REG1A	sampling_country
<<<<<<< HEAD
1	Cohort1	33	Female	control	NA	11.7	1.83222	0.8932192	52.94884	654.282174	1262	United Kingdom
100	Cohort2	51	Male	control	NA	7	0.78039	0.1455889	102.366	461.141	NA	United Kingdom
101	Cohort2	61	Male	control	NA	8	0.70122	0.00280488	60.579	142.95	NA	United Kingdom
102	Cohort2	62	Male	control	NA	9	0.21489	8.5956e-4	65.54	41.088	NA	United Kingdom
105	Cohort2	58	Female	control	NA	11	0.89349	0.00357396	3.73	40.294	NA	United Kingdom
107	Cohort2	56	Female	control	NA	24	0.61074	0.2787785	83.928	19.185	NA	United Kingdom
109	Cohort2	71	Male	control	NA	23	1.05183	0.8603368	243.082	608.284	NA	United Kingdom
110	Cohort2	53	Male	control	NA	7	1.91139	1.516773	150.89	590.686	NA	United Kingdom
111	Cohort2	56	Female	control	NA	12	0.91611	0.5996449	93.811	93.576	NA	United Kingdom
112	Cohort2	60	Female	control	NA	28	0.50895	0.0020358	24.366	19.698	NA	United Kingdom
113	Cohort2	69	Female	control	NA	9	0.41847	0.00167388	17.102	0.03264066	NA	United Kingdom
114	Cohort2	60	Female	control	NA	47	0.80301	0.00321204	3.588	30.071	NA	United Kingdom
115	Cohort2	55	Male	control	NA	17	1.28934	2.285351	67.468	269.805	NA	United Kingdom
116	Cohort1	28	Female	control	NA	8.7	0.50895	0.5830097	13.61906	267.193539	381	United Kingdom
118	Cohort1	50	Female	control	NA	8.7	0.95004	0.00380016	56.399133	192.258882	137	United Kingdom
123	Cohort1	45	Male	control	NA	9.6	1.3572	2.392864	28.509285	353.656656	563	United Kingdom
124	Cohort1	35	Male	control	NA	4	0.24882	9.9528e-4	9.245166	6.03070104	624	United Kingdom
125	Cohort1	30	Male	control	NA	10.8	1.18755	1.600313	22.471281	299.11836	570	United Kingdom
139	Cohort2	87	Male	control	NA	0.05647592	0.06786	2.7144e-4	0.7303665	0.00529308	NA	United Kingdom
140	Cohort2	66	Female	control	NA	4.060258	0.75777	0.008919911	5.41987	8.919911	NA	United Kingdom
141	Cohort2	59	Male	control	NA	0.908578	1.91139	0.06216421	50.1122	62.16421	NA	United Kingdom
142	Cohort2	59	Male	control	NA	3.389304	1.26672	0.007113679	5.22589	7.113679	NA	United Kingdom
143	Cohort2	36	Female	control	NA	5.128234	0.96135	0.01942577	47.254685	19.42577	NA	United Kingdom
144	Cohort2	70	Female	control	NA	1.1359264	0.39585	0.01278068	10.887465	12.78068	NA	United Kingdom
145	Cohort2	63	Female	control	NA	1.9389494	0.42978	0.00171912	5.799405	0.03352284	NA	United Kingdom
146	Cohort2	63	Female	control	NA	2.059078	0.32799	0.00131196	219.8605	0.02558322	NA	United Kingdom
147	Cohort2	59	Male	control	NA	0.5161092	0.88218	0.008404655	8.23218	8.404655	NA	United Kingdom
148	Cohort2	67	Female	control	NA	1.8477128	0.38454	0.001682586	15.06118	1.682586	NA	United Kingdom
149	Cohort2	49	Male	control	NA	2.11638	0.91611	0.01329349	78.4703	13.29349	NA	United Kingdom
150	Cohort2	47	Male	control	NA	2.558004	1.23279	0.04893169	146.7188	48.93169	NA	United Kingdom
151	Cohort2	60	Female	control	NA	6.275096	0.13572	6.47148e-4	3.0346865	0.6471484	NA	United Kingdom
152	Cohort2	60	Female	control	NA	2.370806	0.09048	0.007113679	4.4540935	7.113679	NA	United Kingdom
153	Cohort2	73	Female	control	NA	5.517202	0.20358	8.1432e-4	2.76052	0.01587924	NA	United Kingdom
154	Cohort2	83	Female	control	NA	1.1303358	0.31668	0.00126672	23.192925	0.02470104	NA	United Kingdom
155	Cohort2	60	Female	control	NA	6.223082	0.1131	0.00478765	3.6021425	4.78765	NA	United Kingdom
156	Cohort2	44	Female	control	NA	0.916032	0.12441	0.01764217	13.10085	17.64217	NA	United Kingdom
157	Cohort2	55	Female	control	NA	0.749904	0.4524	6.47148e-4	6.85593	0.6471484	NA	United Kingdom
158	Cohort2	51	Female	control	NA	1.0800212	0.2262	9.048e-4	5.30383	0.0176436	NA	United Kingdom
159	Cohort2	56	Female	control	NA	1.9369218	0.16965	6.786e-4	0.9549	0.0132327	NA	United Kingdom
160	Cohort2	65	Female	control	NA	2.52441	0.70122	0.02898082	60.37345	28.98082	NA	United Kingdom
161	Cohort2	45	Male	control	NA	2.532164	0.37323	0.00149292	12.953345	0.02911194	NA	United Kingdom
162	Cohort2	64	Female	control	NA	0.4571338	0.12441	4.9764e-4	6.53329	0.00970398	NA	United Kingdom
163	Cohort2	26	Female	control	NA	3.527344	0.19227	9.06008e-4	13.02703	0.9060078	NA	United Kingdom
164	Cohort2	34	Female	control	NA	0.8135388	0.53157	0.008662283	7.88036	8.662283	NA	United Kingdom
165	Cohort2	45	Female	control	NA	0.05156496	0.06786	0.01046568	3.222564	10.46568	NA	United Kingdom
166	Cohort2	51	Female	control	NA	0.8303104	0.14703	3.88289e-4	87.5727	0.3882891	NA	United Kingdom
167	Cohort2	67	Female	control	NA	0.7140976	1.09707	0.002976883	14.600835	2.976883	NA	United Kingdom
168	Cohort2	64	Female	control	NA	6.159064	0.4524	9.06008e-4	2.896185	0.9060078	NA	United Kingdom
169	Cohort2	50	Female	control	NA	0	0.53157	0.005046098	5.381445	5.046098	NA	United Kingdom
170	Cohort2	63	Female	control	NA	0.5140028	0.30537	0.005304546	7.56369	5.304546	NA	United Kingdom
171	Cohort2	81	Female	control	NA	25.38502	1.02921	0.003494602	1.6164935	3.494602	NA	United Kingdom
172	Cohort2	71	Male	control	NA	1.9835538	0.14703	1.2943e-4	6.424855	0.1294297	NA	United Kingdom
173	Cohort2	71	Female	control	NA	0.7309476	0.3393	0.003753461	4.948546	3.753461	NA	United Kingdom
174	Cohort2	35	Female	control	NA	0.6488036	0.41847	0.01636817	31.913445	16.36817	NA	United Kingdom
175	Cohort2	57	Female	control	NA	5.025272	0.29406	6.47148e-4	8.23218	0.6471484	NA	United Kingdom
176	Cohort2	64	Male	control	NA	1.2861902	1.06314	0.0237283	27.022365	23.7283	NA	United Kingdom
177	Cohort2	40	Male	control	NA	3.95146	0.27144	1.2943e-4	7.24631	0.1294297	NA	United Kingdom
178	Cohort2	46	Male	control	NA	0.8023578	1.67388	0.007113679	115.367	7.113679	NA	United Kingdom
179	Cohort2	61	Female	control	NA	5.151994	0.76908	0.00307632	8.654645	0.05998824	NA	United Kingdom
180	Cohort2	71	Female	control	NA	1.1787872	0.26013	1.2943e-4	5.22589	0.1294297	NA	United Kingdom
181	Cohort2	38	Female	control	NA	0.13996204	0.30537	0.00122148	9.57219	0.02381886	NA	United Kingdom
182	Cohort2	50	Male	control	NA	1.2029986	1.131	0.004524	49.35476	0.088218	NA	United Kingdom
183	Cohort2	84	Female	control	NA	4.744934	0.49764	0.00199056	17.994015	0.03881592	NA	United Kingdom
26	Cohort1	51	Male	control	NA	6.94	0.19227	0.5711806	3.099211	39.7291311	0	United Kingdom
27	Cohort1	44	Female	control	NA	8.47	0.18096	0.01192871	2.1460546	0.01411488	13.616	United Kingdom
30	Cohort1	58	Female	control	NA	13.58	0.57681	0.8642476	21.571088	0.04499118	65.912	United Kingdom
31	Cohort1	49	Male	control	NA	7.86	0.32799	0.01192871	6.008635	5.63744	0	United Kingdom
33	Cohort1	50	Male	control	NA	3.53	0.57681	0.5356932	17.93163	139.494255	81.61	United Kingdom
34	Cohort1	46	Male	control	NA	6.58	0.35061	0.00140244	2.191019	33.19384	0	United Kingdom
37	Cohort1	58	Male	control	NA	5.8	2.27331	4.855595	83.38125	453.8789	238.262	United Kingdom
41	Cohort1	46	Male	control	NA	3.59	0.13572	5.4288e-4	6.769678	76.5313698	21.204	United Kingdom
42	Cohort1	62	Male	control	NA	7.55	1.11969	0.08618699	3.4968	314.7329367	27.349	United Kingdom
45	Cohort1	52	Male	control	NA	5.7	1.05183	4.637318	54.96901	123.088455	224.656	United Kingdom
46	Cohort1	57	Female	control	NA	37.03	0.49764	0.9993713	3.099211	55.2481521	16.898	United Kingdom
48	Cohort1	40	Male	control	NA	12.84	0.42978	1.056174	1.8277425	33.106275	64.821	United Kingdom
53	Cohort1	54	Male	control	NA	6.77	0.95004	4.61653	54.96901	101.15405	173.162	United Kingdom
54	Cohort1	62	Male	control	NA	10.43	1.93401	7.069545	281.41368	1425.50101	817.732	United Kingdom
55	Cohort1	61	Male	control	NA	7.57	1.40244	1.434706	103.64768	845.422998	278.288	United Kingdom
56	Cohort1	67	Female	control	NA	31.24	0.9048	3.909729	15.873815	93.35045	55.479	United Kingdom
57	Cohort1	40	Female	control	NA	28.18	1.74174	8.223294	93.02112	322.1533	345.323	United Kingdom
58	Cohort1	56	Female	control	NA	18.23	0.87087	3.658579	24.77408	333.4277177	80.386	United Kingdom
74	Cohort2	69	Female	control	NA	9	1.17624	0.901411	44.535	330.166	NA	United Kingdom
75	Cohort1	28	Female	control	NA	84.3	0.32799	0.00131196	7.520023	19.210785	0	United Kingdom
76	Cohort1	30	Female	control	NA	0.6	0.87087	1.174235	22.758806	88.503186	650	United Kingdom
77	Cohort1	41	Female	control	NA	16.4	2.00187	0.1576149	1.7695356	170.088852	110	United Kingdom
84	Cohort2	66	Female	control	NA	28	0.47502	0.00190008	98.933	70.108	NA	United Kingdom
87	Cohort2	63	Male	control	NA	11	1.02921	0.6972028	47.066	170.594	NA	United Kingdom
92	Cohort2	73	Female	control	NA	7	0.14703	5.8812e-4	14.024	16.64	NA	United Kingdom
95	Cohort2	66	Female	control	NA	4	0.3393	0.0013572	9.297	33.307	NA	United Kingdom
96	Cohort2	65	Female	control	NA	34	1.2441	0.2289	17.199	273.424	NA	United Kingdom
98	Cohort2	62	Female	control	NA	3	0.31668	0.1096826	68.926	36.59	NA	United Kingdom
99	Cohort2	76	Female	control	NA	8	0.5655	0.002262	24.317	62.488	NA	United Kingdom
271	Cohort2	32	Female	benign	NA	12	1.16493	5.417692	21.135	445.725	NA	United Kingdom
315	Cohort2	65	Female	benign	NA	13	0.37323	0.228904	13.977	7.367	NA	United Kingdom
344	Cohort2	59	Male	benign	NA	49	0.74646	4.9695	59.362	489.465	NA	United Kingdom
338	Cohort1	52	Male	benign	NA	31.62	0.375492	3.71148	215.57942	656.7924	1305.153	United Kingdom
275	Cohort2	37	Female	benign	NA	9	0.97266	3.669337	45.618	179.403	NA	United Kingdom
321	Cohort2	46	Male	benign	NA	11	0.61074	0.6134921	59.099	8.043	NA	United Kingdom
363	Cohort2	60	Female	benign	NA	8	1.52685	1.446104	42.94	949.133	NA	United Kingdom
365	Cohort2	26	Female	benign	NA	26	0.23751	9.5004e-4	3.68	50.945	NA	United Kingdom
362	Cohort2	28	Female	benign	NA	5	0.44109	0.00176436	10.888	18.613	NA	United Kingdom
364	Cohort2	50	Female	benign	NA	29	0.92742	1.555825	32.086	191.499	NA	United Kingdom
272	Cohort2	38	Female	benign	NA	15	0.16965	0.209901	18.351	0.0132327	NA	United Kingdom
246	Cohort2	68	Male	benign	NA	11	0.76908	4.885849	143.51	780.348	NA	United Kingdom
257	Cohort2	36	Female	benign	NA	17	0.16965	0.480592	19.861	10.06	NA	United Kingdom
316	Cohort2	54	Male	benign	NA	14	1.05183	0.00420732	10.958	9.51	NA	United Kingdom
347	Cohort2	73	Male	benign	NA	9	1.131	4.860454	704.236	3283.593	NA	United Kingdom
368	Cohort1	68	Female	benign	NA	23.17	0.629967	3.143466	43.773464	115.200795	248.831	United Kingdom
369	Cohort1	53	Male	benign	NA	68.72	0.409422	2.399891	137.11362	55.7349981	933.05	United Kingdom
279	Cohort2	36	Female	benign	NA	15	0.9048	0.444877	40.416	651.513	NA	United Kingdom
292	Cohort2	43	Female	benign	NA	9	0.38454	0.00153816	2.45	11.864	NA	United Kingdom
293	Cohort2	56	Female	benign	NA	5	0.4524	1.161454	10.27	80.775	NA	United Kingdom
312	Cohort2	46	Female	benign	NA	6	0.91611	2.548646	28.145	37.51	NA	United Kingdom
336	Cohort2	49	Female	benign	NA	7	0.80301	0.00321204	36.354	89.238	NA	United Kingdom
339	Cohort2	68	Male	benign	NA	8	0.9048	1.006566	11.138	0.0705744	NA	United Kingdom
250	Cohort2	65	Female	benign	NA	17	0.06786	1.415519	101.435	110.68	NA	United Kingdom
351	Cohort2	52	Female	benign	NA	42	0.14703	5.8812e-4	13.78	27.661	NA	United Kingdom
245	Cohort2	53	Male	benign	NA	25	1.3572	4.115126	99.147	425.39	NA	United Kingdom
273	Cohort2	77	Female	benign	NA	37	1.41375	1.035598	90.681	565.79	NA	United Kingdom
265	Cohort2	70	Female	benign	NA	19	0.78039	6.018273	19.017	566.488	NA	United Kingdom
184	Cohort1	39	Female	benign	NA	18	0.80301	1.228042	7.141176	230.4006	38.031	United Kingdom
185	Cohort1	38	Female	benign	NA	26	2.29593	0.00918372	5.3661916	394.7535	45.992	United Kingdom
188	Cohort1	59	Male	benign	NA	323	2.18283	8.99246	193.9833	1683.1656	1861.72	United Kingdom
189	Cohort1	44	Male	benign	NA	2	0.66729	5.458454	9.760545	239.5385	28.957	United Kingdom
190	Cohort1	67	Male	benign	NA	73	1.17624	2.373931	9.158758	4461.684	2146.648	United Kingdom
192	Cohort1	37	Female	benign	NA	6	0.72384	0.7858936	5.3661916	187.5158	21.939	United Kingdom
194	Cohort1	38	Male	benign	NA	10	1.30065	2.526627	2.0792982	399.0176	127.174	United Kingdom
195	Cohort1	71	Male	benign	NA	22	0.89349	3.066153	82.08095	816.9042	121.222	United Kingdom
198	Cohort1	39	Female	benign	NA	12	0.18096	4.440416	29.638637	431.4138	629.319	United Kingdom
199	Cohort1	48	Female	benign	NA	50	0.65598	2.832019	94.11234	431.4251	93.529	United Kingdom
200	Cohort1	66	Male	benign	NA	1541	1.30065	1.213442	15.682107	1227.735	67.867	United Kingdom
201	Cohort1	51	Female	benign	NA	35	0.63336	0.5619396	33.684042	352.9648	76.468	United Kingdom
203	Cohort1	50	Male	benign	NA	24	0.50895	4.053587	19.777954	2206.5318	431.409	United Kingdom
204	Cohort1	70	Female	benign	NA	29	2.32986	7.545234	152.06149	780.1801	519.132	United Kingdom
206	Cohort1	68	Female	benign	NA	28	0.62205	0.3074464	6.1247046	301.795	50.007	United Kingdom
207	Cohort1	64	Male	benign	NA	263	0.52026	6.354206	121.93405	1533.9111	739.568	United Kingdom
209	Cohort1	60	Female	benign	NA	9	1.32327	0.4906815	13.457003	473.5063	72.947	United Kingdom
210	Cohort1	67	Male	benign	NA	1913	1.07445	4.002688	67.564329	651.4553	243.32	United Kingdom
211	Cohort1	44	Male	benign	NA	4	0.57681	0.623018	11.916306	310.2904	88.723	United Kingdom
212	Cohort1	53	Female	benign	NA	11	0.97266	5.794321	43.544725	480.3785	122.719	United Kingdom
213	Cohort1	49	Female	benign	NA	1	0.72384	1.539194	1.9064108	226.9645	88.061	United Kingdom
214	Cohort1	72	Male	benign	NA	72	1.05183	6.975169	164.90691	1053.352	684.967	United Kingdom
215	Cohort1	57	Female	benign	NA	32	0.92742	0.18939849	10.447339	11.06828	95.739	United Kingdom
216	Cohort1	66	Male	benign	NA	86	1.87746	5.224256	48.348643	1202.1696	127.562	United Kingdom
217	Cohort1	47	Male	benign	NA	21	2.02449	5.570366	28.080227	982.9113	131.964	United Kingdom
218	Cohort1	70	Male	benign	NA	64	0.46371	3.626038	458.4545	716.973	88.282	United Kingdom
219	Cohort1	40	Female	benign	NA	13	0.61074	0.3787045	1.0955	236.4138	17.44	United Kingdom
220	Cohort1	53	Female	benign	NA	5	1.37982	2.119438	8.794254	253.5944	88.943	United Kingdom
221	Cohort1	73	Male	benign	NA	107	0.64467	8.502129	228.203675	1438.5585	1465.326	United Kingdom
222	Cohort1	44	Male	benign	NA	20	2.79357	3.870352	34.417047	897.0082	124.193	United Kingdom
285	Cohort2	52	Female	benign	NA	14	0.89349	0.2109439	54.483	140.046	NA	United Kingdom
340	Cohort2	45	Male	benign	NA	17	1.34589	2.641155	188.913	813.874	NA	United Kingdom
356	Cohort1	64	Female	benign	NA	11.04	0.640146	1.020581	29.099014	380.8556	478.127	United Kingdom
319	Cohort2	29	Female	benign	NA	25	1.131	3.565135	240.235	671.283	NA	United Kingdom
233	Cohort1	46	Male	benign	NA	114.8	1.40244	1.669079	11.545359	586.8718	137	United Kingdom
238	Cohort2	42	Male	benign	NA	116	0.31668	0.3040158	11.457	672.536	NA	United Kingdom
234	Cohort2	40	Female	benign	NA	20	0.16965	1.82949	6.586	809.637	NA	United Kingdom
251	Cohort2	40	Male	benign	NA	21	0.62205	1.492887	229.629	463.463	NA	United Kingdom
252	Cohort1	48	Male	benign	NA	46.1	0.76908	0.2609035	4.6447779	69.3152	0	United Kingdom
264	Cohort1	57	Male	benign	NA	12.8	0.42978	0.00171912	12.949153	0.03352284	NA	United Kingdom
267	Cohort2	47	Male	benign	NA	18	0.30537	0.00122148	8.815	96.333	NA	United Kingdom
281	Cohort1	62	Male	benign	NA	30	0.09048	3.6192e-4	3.13	6.26173	0	United Kingdom
349	Cohort1	41	Male	benign	NA	14	2.326467	7.550356	27.431467	581.187009	221.438	United Kingdom
358	Cohort2	57	Male	benign	NA	112	1.04052	4.077191	14.276	480.118	NA	United Kingdom
249	Cohort1	51	Male	benign	NA	19	0.5655	5.196364	51.798747	673.791756	1939	United Kingdom
243	Cohort2	65	Male	benign	NA	21	0.59943	3.488079	479.944	516.538	NA	United Kingdom
244	Cohort1	67	Male	benign	NA	15.2	0.38454	3.742499	96.36501	290.93875	2209.5	United Kingdom
242	Cohort2	61	Female	benign	NA	10	0.20358	0.6800993	54.456	159.966	NA	United Kingdom
241	Cohort2	69	Female	benign	NA	10	0.05655	2.262e-4	5.112	200.165	NA	United Kingdom
286	Cohort1	56	Male	benign	NA	10.9	1.42506	2.733783	255.07832	906.5092	541	United Kingdom
307	Cohort1	67	Female	benign	NA	6.9	0.95004	0.3962199	16.145745	113.6399	334	United Kingdom
366	Cohort1	54	Female	benign	NA	6.8	0.368706	0.6020878	32.76763	246.435651	161.845	United Kingdom
367	Cohort1	46	Male	benign	NA	190.7	1.421667	7.623492	207.52697	1268.768354	1150.648	United Kingdom
322	Cohort2	42	Male	benign	NA	9	0.35061	0.1042893	6.133	107.993	NA	United Kingdom
305	Cohort2	56	Male	benign	NA	4	0.66729	0.9406302	19.427	137.165	NA	United Kingdom
237	Cohort2	46	Male	benign	NA	1	0.89349	0.00357396	15.753	459.471	NA	United Kingdom
240	Cohort2	52	Female	benign	NA	41	0.3393	0.0013572	0.293	73.736	NA	United Kingdom
294	Cohort1	40	Male	benign	NA	7.9	1.00659	1.56621	128.28018	339.0092	4211	United Kingdom
239	Cohort1	29	Male	benign	NA	32.3	0.46371	4.027098	34.0538275	308.7024052	774	United Kingdom
326	Cohort2	58	Male	benign	NA	1	0.82563	0.00330252	5.519	83.18	NA	United Kingdom
248	Cohort2	48	Male	benign	NA	4	1.60602	0.2948	64.311	665.848	NA	United Kingdom
253	Cohort2	66	Female	benign	NA	16	1.16493	4.782489	71.785	466.404	NA	United Kingdom
254	Cohort1	74	Female	benign	NA	16.2	1.93401	3.29401	88.43352	1259.722779	3289	United Kingdom
332	Cohort2	29	Male	benign	NA	13	0.21489	3.719767	12.739	122.842	NA	United Kingdom
337	Cohort1	55	Male	benign	NA	6.71	0.390195	0.00156078	1.4176687	38.3053674	26.407	United Kingdom
287	Cohort2	58	Female	benign	NA	10	0.31668	0.8427024	29.205	65.73	NA	United Kingdom
277	Cohort2	67	Female	benign	NA	11	0.80301	0.00321204	3.751	336.579	NA	United Kingdom
268	Cohort2	47	Female	benign	NA	20	0.39585	0.0015834	10.786	112.488	NA	United Kingdom
270	Cohort2	50	Female	benign	NA	3	0.23751	9.5004e-4	1.234	2.675	NA	United Kingdom
255	Cohort2	66	Male	benign	NA	52	0.37323	0.5924902	19.716	207.646	NA	United Kingdom
235	Cohort2	72	Male	benign	NA	26	0.65598	0.2552534	8.212	204.173	NA	United Kingdom
276	Cohort2	59	Female	benign	NA	6	0.3393	1.115925	21.772	74.864	NA	United Kingdom
236	Cohort2	76	Female	benign	NA	27	0.83694	6.482307	193.916	744.757	NA	United Kingdom
247	Cohort2	40	Female	benign	NA	28	0.31668	0.00126672	2.634	73.684	NA	United Kingdom
266	Cohort2	47	Female	benign	NA	14	0.20358	8.1432e-4	9.728	0.01587924	NA	United Kingdom
330	Cohort2	46	Female	benign	NA	39	0.57681	0.1204693	3.803	0.04499118	NA	United Kingdom
335	Cohort2	75	Female	benign	NA	7	0.54288	3.841183	147.268	146.76	NA	United Kingdom
360	Cohort2	49	Female	benign	NA	20	0.71253	0.6324326	22.602	494.588	NA	United Kingdom
259	Cohort2	53	Female	benign	NA	21	0.4524	0.963804	21.32	78.292	NA	United Kingdom
300	Cohort2	74	Female	benign	NA	13	0.12441	4.9764e-4	1.295	42.667	NA	United Kingdom
456	Cohort1	57	Male	malignant	IA	10	1.73043	2.628425	40.620818	529.984	155.27	United Kingdom
520	Cohort1	55	Male	malignant	IA	11	0.47502	2.830541	33.40615	323.1757697	210.185	United Kingdom
573	Cohort2	58	Male	malignant	IA	11	0.44109	0.6324326	188.253	138.63	NA	United Kingdom
401	Cohort1	73	Male	malignant	IB	3236	0.70122	12.24582	196.92183	1529.183124	432.917	United Kingdom
410	Cohort1	75	Male	malignant	IB	255	0.91611	2.567346	15.695743	297.0097438	98.2	United Kingdom
482	Cohort1	68	Female	malignant	IB	39	0.57681	1.422877	7.085142	0.04499118	39.911	United Kingdom
531	Cohort1	77	Female	malignant	IB	55.6	0.57681	2.081535	22.2442	54.8047404	1186	United Kingdom
534	Cohort1	56	Male	malignant	IB	0.6	0.96135	8.167554	535.2816	1099.519	7301.558	United Kingdom
577	Cohort2	67	Male	malignant	IB	5335	0.49764	1.783212	112.348	47.851	NA	United Kingdom
419	Cohort1	68	Male	malignant	IIA	147	0.49764	5.875759	272.1314	2759.203524	1130.348	United Kingdom
426	Cohort1	67	Male	malignant	IIA	1624	0.21489	5.661984	30.75464	396.7303851	138.9	United Kingdom
427	Cohort1	75	Female	malignant	IIA	279	0.40716	1.722429	41.140085	407.9489428	139.1	United Kingdom
437	Cohort1	64	Female	malignant	IIA	309	0.58812	1.233802	144.47531	1803.014682	384.086	United Kingdom
438	Cohort1	64	Female	malignant	IIA	1972	0.83694	1.406857	13.618654	431.725959	27.737	United Kingdom
441	Cohort1	55	Male	malignant	IIA	1004	1.0179	8.776982	150.18731	1050.39955	462.975	United Kingdom
444	Cohort1	56	Female	malignant	IIA	7	1.06314	0.5924788	29.716092	710.941301	79.423	United Kingdom
451	Cohort1	72	Male	malignant	IIA	328	1.00659	3.402084	241.57924	2428.98803	876.901	United Kingdom
527	Cohort2	48	Male	malignant	IIA	6	0.29406	3.530855	1124.108	6939.098	NA	United Kingdom
530	Cohort1	73	Female	malignant	IIA	354	0.15834	0.24221	34.981375	17.85104	2488	United Kingdom
553	Cohort2	71	Female	malignant	IIA	492	0.99528	1.806422	190.812	736.673	NA	United Kingdom
394	Cohort1	73	Male	malignant	IIB	538	0.76908	2.558491	15.176469	101.3080397	57.678	United Kingdom
396	Cohort1	62	Female	malignant	IIB	1098	1.17624	8.576694	115.91531	2542.312416	469.362	United Kingdom
399	Cohort1	69	Male	malignant	IIB	31000	0.13572	7.786741	222.36613	1541.648682	572.931	United Kingdom
403	Cohort1	66	Male	malignant	IIB	601	0.85956	12.48489	349.06858	3169.306336	2891.127	United Kingdom
404	Cohort1	74	Female	malignant	IIB	554	0.55419	2.589674	88.3939	224.0889854	253.962	United Kingdom
407	Cohort1	77	Male	malignant	IIB	33	0.54288	4.169582	14.657195	287.037653	28.379	United Kingdom
411	Cohort1	77	Male	malignant	IIB	42	0.72384	7.870985	341.27954	2160.879854	48.686	United Kingdom
413	Cohort1	61	Male	malignant	IIB	155	0.84825	4.501495	135.64768	1106.7903	324.38	United Kingdom
414	Cohort1	58	Female	malignant	IIB	66	0.62205	3.829633	92.54805	399.5642504	313.657	United Kingdom
415	Cohort1	69	Female	malignant	IIB	138	0.37323	3.951789	40.101544	698.3854206	89.698	United Kingdom
416	Cohort1	61	Female	malignant	IIB	476	1.131	6.598519	89.43242	345.6235531	330.55	United Kingdom
418	Cohort1	77	Male	malignant	IIB	68	1.22148	5.733242	265.98502	2913.0855	1188.853	United Kingdom
420	Cohort1	62	Male	malignant	IIB	143	0.4524	3.900891	207.30724	164.2566184	709.664	United Kingdom
421	Cohort1	45	Female	malignant	IIB	941	0.47502	1.406857	294.54502	326.9259273	1138.189	United Kingdom
422	Cohort1	67	Female	malignant	IIB	74	0.66729	8.929678	374.51295	3103.221	1457.906	United Kingdom
423	Cohort1	68	Male	malignant	IIB	91	2.30724	6.221869	63.468804	583.1935	78.535	United Kingdom
425	Cohort1	71	Male	malignant	IIB	35	2.19414	4.990122	88.3939	1014.2916	163.791	United Kingdom
429	Cohort1	75	Female	malignant	IIB	600	0.31668	5.336233	229.63598	1466.5077000000001	566.246	United Kingdom
431	Cohort1	63	Female	malignant	IIB	1510	0.64467	8.481769	170.43894	1014.2916	494.08	United Kingdom
432	Cohort1	71	Male	malignant	IIB	1465	0.50895	3.595499	379.70569	2516.134922	2113.577	United Kingdom
433	Cohort1	73	Male	malignant	IIB	1503	0.99528	6.415284	68.661523	572.3529	222.06	United Kingdom
440	Cohort1	54	Female	malignant	IIB	110	0.55419	6.58834	132.53205	811.308	368.808	United Kingdom
442	Cohort1	59	Female	malignant	IIB	231	1.30065	1.101465	20.369188	401.4759	75.738	United Kingdom
443	Cohort1	61	Female	malignant	IIB	64	0.07917	1.66135	12.580106	384.3465	54.075	United Kingdom
447	Cohort1	74	Female	malignant	IIB	100	0.18096	5.733242	167.32331	1037.4162	476.554	United Kingdom
448	Cohort1	73	Female	malignant	IIB	182	0.40716	5.794321	398.91873	1597.5474	2137.891	United Kingdom
449	Cohort1	78	Female	malignant	IIB	345	0.46371	6.384745	76.45064	1045.1244	253.42	United Kingdom
450	Cohort1	70	Male	malignant	IIB	1806	0.26013	4.420057	173.31272	774.0403	447.051	United Kingdom
452	Cohort1	82	Female	malignant	IIB	22	0.36192	5.519468	168.013872	790.121	793.592	United Kingdom
453	Cohort1	58	Male	malignant	IIB	134	0.91611	6.089533	353.88128	1263.5244	1132.737	United Kingdom
454	Cohort1	62	Male	malignant	IIB	62	0.53157	3.615858	13.563616	5.7868	54.922	United Kingdom
455	Cohort1	76	Female	malignant	IIB	30	0.2262	5.621266	406.73064	897.708948	1410.928	United Kingdom
461	Cohort1	79	Female	malignant	IIB	1636	0.26013	3.249388	18.368096	139.494255	77.328	United Kingdom
465	Cohort1	68	Male	malignant	IIB	1475	0.27144	7.056607	389.51456	1632.246564	1315.32	United Kingdom
466	Cohort1	70	Male	malignant	IIB	285	0.23751	7.066786	31.580432	211.768464	188.206	United Kingdom
471	Cohort1	62	Female	malignant	IIB	318	1.36851	3.035614	168.10784	941.162229	334.069	United Kingdom
472	Cohort1	73	Male	malignant	IIB	275	0.46371	5.478749	104.8488	546.979251	882.504	United Kingdom
473	Cohort1	72	Male	malignant	IIB	4115	0.59943	7.250022	508.82592	874.652139	2255.048	United Kingdom
475	Cohort1	79	Male	malignant	IIB	737	1.08576	2.81166	176.91608	1337.828832	298.371	United Kingdom
477	Cohort1	78	Male	malignant	IIB	457	1.28934	3.93143	11.96212	238.3725	2024.821	United Kingdom
485	Cohort1	59	Male	malignant	IIB	248.8	0.31668	1.50568	3.859414	0.02470104	118.544	United Kingdom
489	Cohort1	66	Male	malignant	IIB	36.27	1.22148	10.02264	367.5602	982.068504	1310.506	United Kingdom
490	Cohort1	80	Male	malignant	IIB	167.5	0.82563	6.142692	76.4383	672.948933	378.253	United Kingdom
525	Cohort1	63	Male	malignant	IIB	523	0.31668	0.00126672	1.7695356	0.02470104	111	United Kingdom
537	Cohort1	44	Male	malignant	IIB	158	1.73043	2.143292	118.5044	171.078084	2581	United Kingdom
538	Cohort2	76	Male	malignant	IIB	198	0.18096	1.013392	123.01	929.408	NA	United Kingdom
540	Cohort2	70	Female	malignant	IIB	259	0.10179	4.230177	55.88	45.233	NA	United Kingdom
541	Cohort1	60	Female	malignant	IIB	1749	0.38454	5.608244	137.76847	1730.681586	313	United Kingdom
543	Cohort2	77	Female	malignant	IIB	12	0.72384	9.56575	193.089	844.044	NA	United Kingdom
544	Cohort2	79	Female	malignant	IIB	33	1.51554	11.21034	1215.168	951.085	NA	United Kingdom
545	Cohort2	71	Male	malignant	IIB	434	0.1131	0.7735073	149.629	98.272	NA	United Kingdom
546	Cohort2	77	Female	malignant	IIB	5236	0.18096	7.140791	40.543	196.062	NA	United Kingdom
547	Cohort1	67	Male	malignant	IIB	15	0.32799	5.207928	80.119575	663.593631	3978	United Kingdom
551	Cohort2	58	Male	malignant	IIB	744	1.06314	1.14499	4.729	155.445	NA	United Kingdom
552	Cohort2	73	Female	malignant	IIB	2203	2.77095	12.794	1037.972	4225.523	NA	United Kingdom
557	Cohort1	52	Female	malignant	IIB	41	0.23751	4.452146	13.404489	8.422872	693	United Kingdom
561	Cohort2	53	Female	malignant	IIB	2478	1.2441	5.772537	750.559	2416.474	NA	United Kingdom
564	Cohort1	61	Male	malignant	IIB	6.9	1.90008	4.458313	163.83717	819.146	573.508	United Kingdom
567	Cohort1	66	Male	malignant	IIB	11740	0.73515	3.193714	10.755955	279.6968	57.48	United Kingdom
572	Cohort2	66	Female	malignant	IIB	936	4.11684	10.73328	1195.972	13344.3	NA	United Kingdom
392	Cohort1	72	Male	malignant	III	509	0.54288	10.36449	64.606514	362.4514341	206.892	United Kingdom
393	Cohort1	66	Female	malignant	III	537	0.97266	13.72179	582.43575	3092.892	3761.625	United Kingdom
395	Cohort1	55	Male	malignant	III	181	0.50895	2.225879	24.173807	355.8191	82.651	United Kingdom
397	Cohort1	65	Female	malignant	III	216	1.21017	5.500031	7.644714	412.3117992	58.124	United Kingdom
398	Cohort1	72	Female	malignant	III	655	0.32799	9.044431	215.75232	620.14035	464.054	United Kingdom
400	Cohort1	76	Male	malignant	III	1621	3.52872	23.890323	23.156637	3555.722632	107.152	United Kingdom
402	Cohort1	60	Male	malignant	III	859	0.74646	0.3164277	65.794463	1194.49596	239.846	United Kingdom
405	Cohort1	57	Male	malignant	III	244	2.97453	10.56197	8.407595	717.423889	30.435	United Kingdom
406	Cohort1	65	Female	malignant	III	1471	0.41847	7.713981	99.44473	1203.844684	245.385	United Kingdom
408	Cohort1	78	Female	malignant	III	8634	0.83694	13.01499	414.26168	3272.766378	1626.674	United Kingdom
409	Cohort1	69	Female	malignant	III	556	0.91611	7.494335	77.32123	1423.229437	1232.933	United Kingdom
412	Cohort1	68	Female	malignant	III	295	0.99528	5.305694	40.957196	2240.656936	171.785	United Kingdom
417	Cohort1	58	Male	malignant	III	1075	0.54288	2.139798	236.50907	337.521296	77.989	United Kingdom
424	Cohort1	68	Male	malignant	III	103	0.2262	10.49736	108.27124	456.1572	387.264	United Kingdom
428	Cohort1	70	Male	malignant	III	291	1.75305	5.784141	36.125614	761.4703	139.133	United Kingdom
430	Cohort1	62	Male	malignant	III	60	1.49292	4.847606	483.53942	890.3848	1784.47	United Kingdom
434	Cohort1	51	Male	malignant	III	1120	0.32799	5.132638	54.163914	618.6735912	270.122	United Kingdom
435	Cohort1	69	Female	malignant	III	8978	1.21017	13.11355	967.17125	3417.822	2173.867	United Kingdom
436	Cohort1	67	Male	malignant	III	755	0.37323	9.672798	369.25658	2719.3533	1646.49	United Kingdom
439	Cohort1	67	Female	malignant	III	1990	1.66257	12.06503	939.61975	6035.157	3088.108	United Kingdom
445	Cohort1	50	Male	malignant	III	129	0.42978	1.457756	62.254731	393.9007	205.046	United Kingdom
446	Cohort1	77	Female	malignant	III	9250	0.21489	1.712249	20.536467	232.7158	56.19	United Kingdom
457	Cohort1	83	Male	malignant	III	43	0.4524	5.82486	19.087936	393.0478	112.523	United Kingdom
458	Cohort1	59	Male	malignant	III	553	0.47502	3.096692	106.8193	605.4024	435.116	United Kingdom
459	Cohort1	76	Female	malignant	III	120	2.25069	3.982329	71.21814	523.5307	290.48	United Kingdom
460	Cohort1	56	Male	malignant	III	1	3.21204	4.481135	94.61319	993.44	378.364	United Kingdom
462	Cohort1	39	Male	malignant	III	523	2.31855	1.620632	13.747762	301.795	201.632	United Kingdom
463	Cohort1	63	Male	malignant	III	49	1.02921	9.469203	21.630868	990.8814	118.997	United Kingdom
464	Cohort1	39	Male	malignant	III	299	2.04711	3.707476	99.19049	722.2401	521.851	United Kingdom
467	Cohort1	70	Male	malignant	III	2114	1.56078	6.358314	788.08725	3210.585	3658.172	United Kingdom
468	Cohort1	68	Male	malignant	III	1435	0.97266	8.186557	86.22152	869.5662	372.264	United Kingdom
469	Cohort1	78	Male	malignant	III	30	1.28934	7.3111	42.027692	619.0477	159.883	United Kingdom
470	Cohort1	73	Female	malignant	III	551	0.82563	5.723063	62.317864	358.9346	211.533	United Kingdom
474	Cohort1	75	Female	malignant	III	2454	0.75777	13.840416	132.24869	2075.596306	485.779	United Kingdom
476	Cohort1	83	Male	malignant	III	3435	1.14231	10.71113	225.06589	1266.132	821.228	United Kingdom
478	Cohort1	54	Female	malignant	III	399	1.27803	6.985349	26.716746	769.9986	116.715	United Kingdom
479	Cohort1	60	Male	malignant	III	9436	0.53157	3.306537	249.90294	645.857496	8400	United Kingdom
480	Cohort1	66	Male	malignant	III	5855	2.66916	13.20467	526.52985	2557.174	1528.949	United Kingdom
481	Cohort1	64	Female	malignant	III	641	0.89349	5.184534	25.63308	747.793791	96.798	United Kingdom
483	Cohort1	57	Male	malignant	III	3985	0.81432	0.2517946	340.948	361.636446	1036.464	United Kingdom
486	Cohort1	64	Male	malignant	III	69.75	2.83881	12.55407	489.043475	2819.21352	2016.66	United Kingdom
487	Cohort1	61	Male	malignant	III	783.2	0.36192	5.160876	103.85698	82.9047123	339.071	United Kingdom
488	Cohort1	67	Male	malignant	III	644.8	0.81432	6.190009	779.647	28.5652839	1841.226	United Kingdom
491	Cohort1	68	Male	malignant	III	1318	2.1489	0.8195919	38.536	432.009891	238.411	United Kingdom
492	Cohort1	71	Male	malignant	III	3.04	0.66729	6.627686	244.1762	598.616673	882.387	United Kingdom
493	Cohort1	78	Male	malignant	III	305.9	1.67388	10.83885	520.583225	447.388941	2007.324	United Kingdom
494	Cohort1	82	Male	malignant	III	16.92	0.31668	1.257269	19.988054	0.02470104	57.708	United Kingdom
521	Cohort1	75	Male	malignant	III	1485	0.99528	8.934363	541.05345	3507.252574	1723.524	United Kingdom
523	Cohort1	60	Female	malignant	III	147.7	0.20358	3.934431	66.46248	390.015483	2529	United Kingdom
528	Cohort1	68	Female	malignant	III	2484	0.26013	7.479967	200.6403	1127.803	NA	United Kingdom
532	Cohort1	48	Female	malignant	III	1555	0.26013	0.652121	1.6517835	39.97348	169	United Kingdom
533	Cohort1	68	Male	malignant	III	422	0.28275	1.706775	2.6321085	25.0969224	0	United Kingdom
536	Cohort1	60	Male	malignant	III	2204	1.60602	2.236909	305.03568	2805.294618	8731	United Kingdom
542	Cohort1	56	Male	malignant	III	57	0.35061	3.872582	278.07025	0.02734758	5000	United Kingdom
550	Cohort1	50	Male	malignant	III	885	0.9048	1.43423	50.632904	15.27972	1612	United Kingdom
562	Cohort1	29	Male	malignant	III	468.3	2.80488	5.137218	918.73803	2207.57	1926.084	United Kingdom
563	Cohort1	53	Male	malignant	III	18360	0.64467	6.781464	110.14199	434.5447	389.095	United Kingdom
565	Cohort1	63	Female	malignant	III	433	0.29406	3.199987	193.186	321.52905	624.345	United Kingdom
568	Cohort1	72	Female	malignant	III	14.67	0.16965	1.943358	4.5576885	37.13591	19.163	United Kingdom
569	Cohort1	75	Female	malignant	III	2202	1.59471	9.667768	559.54752	1780.5552	1788.392	United Kingdom
570	Cohort1	73	Male	malignant	III	1916	1.31196	5.917939	381.221725	1911.565138	369.344	United Kingdom
571	Cohort1	53	Female	malignant	III	633	2.00187	6.331958	22.76232	495.7253	143.535	United Kingdom
574	Cohort1	80	Female	malignant	III	84	0.93873	5.109575	232.920875	3418.00053	719.394	United Kingdom
575	Cohort1	42	Female	malignant	III	19.16	0.4524	0.4877182	111.71032	605.8256	NA	United Kingdom
576	Cohort1	47	Female	malignant	III	99.6	2.32986	2.037585	8.754893	665.5326	61.058	United Kingdom
484	Cohort1	44	Female	malignant	IV	271.7	2.42034	9.005338	144.98504	2856.12324	545.611	United Kingdom
495	Cohort1	58	Male	malignant	IV	710.8	0.19227	3.055294	32.89096	196.709982	190.765	United Kingdom
519	Cohort1	78	Female	malignant	IV	941	0.46371	1.044345	14.36436	327.3970973	646	United Kingdom
529	Cohort1	61	Female	malignant	IV	13740	0.32799	5.232527	123.10473	755.820867	2331.5	United Kingdom
590	Cohort1	74	Male	malignant	IV	1488	1.50423	8.200958	411.938275	2021.321078	13200	United Kingdom
